Simtra BioPharma Solutions has purchased a 65-acre property with more than 300,000 square feet of available space for ...

The European Commission has approved Sanofi’s Sarclisa in combination with bortezomib, lenalidomide, and dexamethasone (VRd) ...

Bristol Myers Squibb has appointed Cristian Massacesi, M.D., as Executive Vice President, Chief Medical Officer, and Head of Development.

Matchpoint Therapeutics has entered into an exclusive option and license agreement with Novartis to develop and commercialize oral covalent inhibitors.

Tablet lubricants play a key role in pharmaceutical manufacturing, affecting everything from compression behavior to tablet ...

Stevanato Group has secured €200 million in financing intended to support its ongoing capital expenditure projects in ...

BGENE-DMD is designed to treat Duchenne muscular dystrophy (DMD) via a one-time administration in a single AAV.

AstraZeneca has announced a $50 billion investment in the United States by 2030, creating tens of thousands of new, highly ...

Roquette, a provider of plant-based ingredients and pharmaceutical excipients, has launched POLYOX Extended Stability (ES) ...

Abzena, an end-to-end integrated CDMO and CRO, has appointed Geoffrey M. Glass as Chief Executive Officer (CEO), effective ...

Jeff Sheehan, Managing Partner at Trinity Capital, Spark’s developer, commented, “Coriolis Pharma’s decision to establish ...

Cycle Pharmaceuticals has awarded LeMed Specialty Pharmacy the exclusive contract for specialty pharmacy distribution and ...